These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8076659)

  • 1. ACE inhibition, atherosclerosis and myocardial infarction--the AIRE Study in practice. Acute Infarction Ramipril Efficacy Study.
    Ball SG; Hall AS; Murray GD
    Eur Heart J; 1994 May; 15 Suppl B():20-5; discussion 26-30. PubMed ID: 8076659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators.
    Cleland JG; Erhardt L; Murray G; Hall AS; Ball SG
    Eur Heart J; 1997 Jan; 18(1):41-51. PubMed ID: 9049514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.
    Lancet; 1993 Oct; 342(8875):821-8. PubMed ID: 8104270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE-inhibitor therapy after myocardial infarction--a new treatment strategy.
    Hall AS; Ball SG
    Z Kardiol; 1994; 83 Suppl 4():57-62. PubMed ID: 7856281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who should be treated with angiotensin-converting enzyme inhibitors after myocardial infarction?
    Ball SG; Hall AS
    Am Heart J; 1996 Jul; 132(1 Pt 2 Su):244-50. PubMed ID: 8677863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
    Young JB
    Cardiol Clin; 1995 Aug; 13(3):379-90. PubMed ID: 7585774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How ACE inhibitors reduce death from myocardial infarction: hypotheses from the AIRE study. Acute Infarction Ramipril Efficacy study.
    Ball SG; Hall AS
    Br J Clin Pract Suppl; 1996 Jul; 84():31-5. PubMed ID: 8995000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study. Acute Infarction Ramipril Efficacy.
    Hall AS; Murray GD; Ball SG
    Lancet; 1997 May; 349(9064):1493-7. PubMed ID: 9167457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival benefit of ramipril in patients with acute myocardial infarction complicated by heart failure.
    Wu J; Hall AS; Gale CP;
    Heart; 2021 Mar; 107(5):389-395. PubMed ID: 33452123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trials with ACE-inhibitors in acute myocardial infarction].
    Dalla Volta S
    Cardiologia; 1994 Dec; 39(12 Suppl 1):149-55. PubMed ID: 7634258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ramipril. An updated review of its therapeutic use in essential hypertension and heart failure.
    Frampton JE; Peters DH
    Drugs; 1995 Mar; 49(3):440-66. PubMed ID: 7774515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct].
    Mazzotta G; Vecchio C
    G Ital Cardiol; 1994 Jan; 24(1):59-70. PubMed ID: 8200499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of ramipril in heart failure after myocardial infarction. Economic evaluation of the Acute Infarction Ramipril Efficacy (AIRE) study for Germany from the perspective of Statutory Health Insurance.
    Schädlich PK; Huppertz E; Brecht JG
    Pharmacoeconomics; 1998 Dec; 14(6):653-69. PubMed ID: 10346417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical course of heart failure and its modification by ACE inhibitors: insights from recent clinical trials.
    Cleland JG
    Eur Heart J; 1994 Jan; 15(1):125-30. PubMed ID: 8174572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indications for ACE inhibitors in the postinfarct period].
    Ertl G; Gaudron P; Neubauer S; Hu K; Zdrojewski T; Horn M; Kochsiek K
    Z Kardiol; 1994; 83 Suppl 4():65-74. PubMed ID: 7856283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lisinopril. A review of its pharmacology and clinical efficacy in the early management of acute myocardial infarction.
    Goa KL; Balfour JA; Zuanetti G
    Drugs; 1996 Oct; 52(4):564-88. PubMed ID: 8891468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of primary and secondary outcomes and classification of mode of death among patients with clinical evidence of heart failure after a myocardial infarction: a report from the Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.
    Cleland JG; Erhardt L; Hall AS; Winter C; Ball SG
    J Cardiovasc Pharmacol; 1993; 22 Suppl 9():S22-7. PubMed ID: 7514237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C; Munger MA
    Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications for the Acute Infarction Ramipril Efficacy extension (AIREX) Study.
    Spargias KS; Ball SG
    Int J Clin Pract Suppl; 1998 May; 94():32-6. PubMed ID: 9926443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: evidence from the AIRE study.
    Spargias KS; Hall AS; Greenwood DC; Ball SG
    Heart; 1999 Jan; 81(1):25-32. PubMed ID: 10220541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.